Josh P. Frederick

Statistics

Publications

Citations

191

H-Index

Active since

2018

Affiliations

Moderna Therapeutics (United States)(Current)

Josh P. Frederick is an author at Moderna Therapeutics (United States) specializing in oncology, cancer immunotherapy, and messenger rna therapeutics.

Publications per year

2018–2021

Publications

MicroRNAs Enable mRNA Therapeutics to Selectively Program Cancer Cells to Self-Destruct

Ruchi Jain, Josh P. Frederick, Eric Yi‐Hsiu Huang et al. · Nucleic Acid Therapeutics · 2018 · 162 citations · Full text

Life Sciences, Biotechnology, Oncology +17

539 Phase 1 study of mRNA-2752, a lipid nanoparticle encapsulating mRNAs encoding human OX40L/IL-23/IL-36γ, for intratumoral (ITu) injection +/- durvalumab in advanced solid tumors and lymphoma

Manish R. Patel, Antonio Jimeno, Ding Wang et al. · Regular and Young Investigator Award Abstracts · 2021 · 29 citations · Full text

Medicine, Oncology, Pharmacology +17

1–2 of 2